Compared with exosomes derived from benign ovarian lesions, exosomes from ovarian cancer contain significantly increased levels of TGFβ1 and melanoma-associated antigens MAGE3 and MAGE6, suggesting potential biomarkers for distinguishing malignancy from benignity. The gene discussed is TGFB1; the disease is ovarian cancer.